title: [Discontinuation syndrome associated with antidepressants].
abstract: Sometimes, the discontinuation of antidepressant therapy is associated with both physical and psychological symptoms. These symptoms are parts of the discontinuation syndrome and are very different from relapse or recurrence. The discontinuation syndrome appears within 1 week and lasts about 3 weeks after discontinuation of the antidepressant. In the vast majority of cases, the symptomatology is self-limiting. Sometimes, in the presence of a severe syndrome, reintroduction of the antidepressant induces a rapid resolution of the symptoms. In fact, the discontinuation of the antidepressant should be progressive.
authors: Service de Psychiatrie et de Psychologie Médicale, CHU Sart Tilman, Lìege, Belgique.
authors: W
authors: W
authors: Pitchot
authors: G
authors: G
authors: Scantamburlo
authors: E
authors: E
authors: Pinto
authors: M
authors: M
authors: Ansseau
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000009:adverse effects; D017109:Akathisia, Drug-Induced / Q000209:etiology; D014151:Anti-Anxiety Agents / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects*; D000929:Antidepressive Agents, Tricyclic / Q000009:adverse effects; D006801:Humans; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D017367:Selective Serotonin Reuptake Inhibitors / Q000009:adverse effects; D013315:Stress, Psychological / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome; D014149:Tranquilizing Agents / Q000009:adverse effects
chemical_list: D018759:Adrenergic Uptake Inhibitors; D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D000929:Antidepressive Agents, Tricyclic; D008996:Monoamine Oxidase Inhibitors; D017367:Selective Serotonin Reuptake Inhibitors; D014149:Tranquilizing Agents